Error: Could not add to watchlist. X

UBS Lux Equity Fund - Biotech USD

+ Watchlist
UBFC:TH
Tradegate
369.55
EUR
0.00
0.00%
As of 09:55:10 ET on 02/08/2016.
Previous Close
369.55
52Wk Range
369.55 - 652.78
1 Yr Return
-27.39%
Volume
38
Previous Close
369.55
52Wk Range
369.55 - 652.78
1 Yr Return
-30.56%
NAV (on -)
0
Total Assets (b USD) (on 02/05/2016)
1.087
Inception Date
10/15/1996
Premium/Discount
-
Average 52-Week Premium
-
Fund Managers
NATHALIE LOTSCHER PETRUS / CHRISTIAN SUTER
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Expense Ratio
2.08%
3 Mo Return
-
3 Yr Return
-
5 Yr Return
-
Top Fund Holdings
Name Position Value % of Fund
Gilead Sciences Inc 1.30 m 131.45 m 8.71
Biogen Inc 374.58 k 114.75 m 7.61
Amgen Inc 668.62 k 108.54 m 7.19
Celgene Corp 815.45 k 97.66 m 6.47
AbbVie Inc 1.61 m 95.36 m 6.32
BioMarin Pharmaceutical Inc 704.78 k 73.83 m 4.89
Regeneron Pharmaceuticals Inc 131.73 k 71.51 m 4.74
Vertex Pharmaceuticals Inc 563.83 k 70.95 m 4.70
Baxalta Inc 1.63 m 63.55 m 4.21
Incyte Corp 557.91 k 60.51 m 4.01
Profile
UBS Lux Equity Fund - Biotech USD is an open-end investment fund incorporated in Luxembourg. The Fund's objective is medium- to long-term capital growth. The Fund invests globally in equities of companies engaged in research, product development, product manufacturing and distribution in the biotechnology sector.
ADDRESS
UBS Equity Fund Management Company
33A avenue J.F. Kennedy
L-1855 Luxembourg
Luxembourg
PHONE
352-44-10-10-1 Tel